Abstract Although beat-to-beat variability (short-term variability, SV) of action potential duration (APD) is considered as a predictor of imminent cardiac arrhythmias, the underlying mechanisms are still not clear. In the present study, therefore, we aimed to determine the role of the major cardiac ion currents, APD, stimulation frequency, and changes in the intracellular Ca 2+ concentration ([Ca 2+ ] i ) on the magnitude of SV. Action potentials were recorded from isolated canine ventricular cardiomyocytes using conventional microelectrode techniques. SV was an exponential function of APD, when APD was modified by current injections. Drug effects were characterized as relative SV changes by comparing the drug-induced changes in SV to those in APD according to the exponential function obtained with current pulses. Relative SV was increased by dofetilide, HMR 1556, nisoldipine, and veratridine, while it was reduced by BAY K8644, tetrodotoxin, lidocaine, and isoproterenol. Relative SV was also increased by increasing the stimulation frequency and [Ca 2+ ] i . In summary, relative SV is decreased by ion currents involved in the negative feedback regulation of APD (I Ca , I Ks , and I Kr ), while it is increased by I Na and I to . We conclude that drug-induced effects on SV should be evaluated in relation with the concomitant changes in APD. Since relative SV was decreased by ion currents playing critical role in the negative feedback regulation of APD, blockade of these currents, or the beta-adrenergic pathway, may carry also some additional proarrhythmic risk in addition to their well-known antiarrhythmic action.
Introduction
Beat-to-beat variability of action potential duration (also called short-term variability, SV) is an intrinsic property of various in vivo and in vitro mammalian cardiac preparations including the human heart [7, 8, 21] . In spite of the fact that SV is considered one of the best proarrhythmic predictors [1, 11, 22] (but see also Michael et al. [17] ), its exact ionic mechanism is poorly understood. Involvement of many factors, such as stochastic gating of ion channels [14, 18] , cell-tocell coupling [27] , action potential duration and morphology [6] , stimulation frequency [12] , and intracellular calcium handling [13] in modulation of SV, have been reported; however, neither their relative contribution nor the role of the specific cardiac ion currents has been identified in a well-defined experimental model. Therefore, in absence of relevant human cellular electrophysiological data, canine ventricular myocytes were chosen to analyze experimentally the determinants of SV in the present study due to two reasons. (1) Canine ventricular myocytes are believed to resemble human ventricular cells regarding their action potential morphology and kinetics of the underlying ion currents [19, 20] , and (2) a large mass of in vitro and in vivo experimental data on beat-to-beat variability have been obtained in this species [1, 12, 13, 15, 22, 23] .
Methods

Isolation of single canine ventricular myocytes
Adult mongrel dogs of either sex were anesthetized with intramuscular injections of 10 mg/kg ketamine hydrochloride (Calypsol, Richter Gedeon, Hungary)+1 mg/kg xylazine hydrochloride (Sedaxylan, Eurovet Animal Health BV, The Netherlands) according to protocols approved by the local ethical committee (license no. 18/2012/DEMÁB) in line with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The hearts were quickly removed and placed in Tyrode solution. Single myocytes were obtained by enzymatic dispersion using the segment perfusion technique, as described previously [2, 3, 9, 16] . Briefly, a wedge-shaped section of the ventricular wall supplied by the left anterior descending coronary artery was dissected, cannulated, and perfused with oxygenized Tyrode solution. After removal of blood, the perfusion was switched to a nominally Ca 2+ -free Joklik solution (Minimum Essential Medium Eagle, Joklik Modification, Sigma) for 5 min. This was followed by 30 min perfusion with Joklik solution supplemented with 1 mg/ml collagenase (Type II. Worthington, Chemical Co.) and 0.2 % bovine serum albumin (Fraction V., Sigma) containing 50 μM Ca
2+
. All other drugs were obtained from Sigma-Aldrich Co. (St. Louis, MO, USA). After gradually restoring the normal external Ca 2+ concentration, the cells were stored in Minimum Essential Medium Eagle until use.
Recording of action potentials
All electrophysiological measurements were performed at 37°C. The rod-shaped viable cells showing clear striation were sedimented in a plexiglass chamber of 1 ml volume allowing continuous superfusion (at a rate of 2 ml/min) with modified Krebs solution gassed with a mixture of 95 % O 2 and 5 % CO 2 at pH=7.4. The modified Krebs solution contained (in mM): NaCl, 128.3; NaHCO 3 , 21.4; KCl, 4.0; CaCl 2 , 1.8; MgCl 2 , 0.42; and glucose 10. Transmembrane potentials were recorded using 3 M KCl filled sharp glass microelectrodes having tip resistance between 20 and 40 MΩ. These electrodes were connected to the input of Multiclamp 700A, 700B or Axoclamp-2B amplifiers (Molecular Devices, Sunnyvale, CA, USA). The cells were paced through the recording electrode at steady cycle length of 1 s using 1-2 ms wide rectangular current pulses having amplitudes of twice the diastolic threshold. Since the cytosol was not dialyzed, time-dependent changes in action potential morphology were negligible for the period of our experimental protocol lasting typically not longer than 25 min, as was demonstrated in Fig. 1e . Action potentials were digitized (at 200 kHz using Digidata 1322A, 1440A, and 1200 A/D card, purchased from Axon Instruments Inc., Foster City, CA, USA) and stored for later analysis. Series of 50 consecutive action potentials were analyzed to estimate SV according to the following formula:
where SV is short-term variability, APD n and APD n + 1 indicate the durations of the nth and n + 1th APs, respectively, at 90 % level of repolarization, and n beats denotes the number of consecutive beats analyzed [12] . Changes in SV were typically presented as Poincaré plots where 50 consecutive APD values are plotted, each against the duration of the previous action potential.
Here is to be mentioned that all action potentials analyzed in the present study were normally driven ones, records taken in myocytes displaying early or delayed afterdepolarizations were excluded from evaluation.
Statistics
Results are expressed as mean ± SEM values. Statistical significance of differences was evaluated using one-way ANOVA followed by Student's t test. Differences were considered significant when p was less than 0.05. Each given n value represents the number of cells/number of animals.
Results
Transmural distribution of SV
Since considerable differences are known to exist in the set and densities of ion currents, resulting in different action potential morphologies, in the various layers of the ventricular wall, SV was compared in myocytes dispersed from the subepicardial (EPI), subendocardial (ENDO), and midmyocardial (MID) regions of the left ventricle. SV was the greatest in the MID cells (2.93±0.07 ms), smallest in EPI cells (2.16±0.17 ms), and had an intermediate level in ENDO myocytes (2.53±0.16 ms) as demonstrated in Fig. 1a -c. Although all these transmural differences in APD and SV were statistically significant when analyzed using ANOVA (p<0.05), they were not related to the spike-and-dome configuration of action potentials observed in EPI or MID cells. When the transient outward K + current (I to ) was suppressed by 1 mM 4-aminopyridine in EPI cells, the spike-and-dome action potential morphology disappeared but SV decreased slightly (by 0.57±0.49 ms, N.S., n=9/6) instead of increasing. This concentration of 4-aminopyridine failed to modify APD significantly (not shown). As shown in Fig. 1d , the observed transmural distribution of SV was largely proportional to APD values. Therefore, the relationship between SV and APD was further studied.
Relationship between SV and APD
To study the dependence of SV on APD, outward and inward current injections were applied in current clamp mode. The current pulses, having amplitudes varied from −600 to + 70 pA, were injected throughout the full duration of the action potential except phase 0 (Fig. 2a, b) . These experiments, similarly to all results discussed in the followings, were performed in midmyocardial cells. Using current pulses of various amplitudes allowed the modification of APD within a reasonably wide range (from 20 to 500 ms) in a way not related to exclusive interaction with one or another specific ion current. The results obtained by analyzing 117 data points (i.e., corresponding SV and APD values, each representing a group of 50 consecutive action potentials) are presented in Fig. 2c -e. As shown in Fig. 2c , the SV-APD relationship follows exponential kinetics. Similarly, an exponential relationship was observed when the current-induced changes in SV and APD were analyzed (Fig. 2d) . Furthermore, when the relative change in SV (defined as ΔSV/ΔAPD) was plotted against the current-induced change in APD (ΔAPD), this relationship could also be fitted to an exponential function. From the ΔSV versus ΔAPD and ΔSV/ΔAPD versus ΔAPD relations, one can estimate that a change in SV caused by any given drug or intervention is greater or less than the value predicted by the concomitant change in APD. The equations used for the fitting procedure together with their numerical solutions are presented in Table 1 . The most important conclusion from these experiments is that any drug-induced change in SV must be evaluated in terms of relative SV, i.e., by comparing changes in SV to concomitant changes in APD. Since the duration of a cardiac action potential is strongly influenced by the frequency of stimulation, it was reasonable to study whether the frequency-dependent changes in SV are in line with the predictions of the APD changes. Both APD and SV increased with lengthening of pacing cycle length ( Fig. 3a-d ). When each SV was plotted as a function of the corresponding APD value, and the exponential curve obtained from the experiments presented previously in Fig. 2 . was superimposed, the experimental data gave a good fit to the curve-at least for cycle lengths longer than 0.5 s. SV values obtained at higher frequencies were larger than predicted by the APD-SV relationship indicating the possible contribution of factors other than APD at higher pacing frequencies (Fig. 3e) . Using the non-injected data (zero current) as reference, the current-induced changes in SV (ΔSV) were plotted against the current-induced changes in APD (ΔAPD) in d. Finally, the ΔSV/ ΔAPD ratios were plotted as a function of the corresponding ΔAPD value (e). Solid curves were generated by fitting data to monoexponential functions in order to obtain the SV vs APD, ΔSV vs ΔAPD, and ΔSV/ ΔAPD vs ΔAPD relationships (estimated parameters in Table 1 chelator. Exposure of the cells to the Ca 2+ ionophore A 23187 (1 μM for 25 min) significantly shortened, while loading the cells with the cell-permeant acetoxy-methylesther form of the Ca 2+ chelator BAPTA (using 5 μM BAPTA-AM for 25 min) strongly lengthened APD, although SV was not modified significantly by these interventions (Fig. 4a-d) . However, as demonstrated in Fig. 4e , A 23187 increased, while BAPTA-AM decreased the relative SV when it was expressed as a function of APD change, i.e., as a ΔSV/ΔAPD ratio.
Effect of changes in [Ca
Contribution of the major ion currents to modulation of beat-to-beat variability: role of K + currents
The role of the various ion currents in modulation of SV can be best studied by using their selective activators and inhibitors. Contribution of five K + currents, the rapid delayed rectifier (I Kr ), the slow delayed rectifier (I Ks ), the transient outward current (I to ), and the inward rectifier (I K1 ) was studied using their specific blockers: dofetilide, HMR 1556, chromanol 293B in the presence of HMR 1556, and BaCl 2 , respectively. The ATP-sensitive K + current (I K-ATP ) was activated by lemakalim (Fig. 5a-e) . Plotting the results in the way as it was done in Fig. 2c -e revealed the specific effects of these agents on SV both absolutely and relatively ( Fig. 5f-h) . Accordingly, the I Kr inhibitor dofetilide (10, 30, 100, and 300 nM) increased both APD and SV; however, its effect on SV was significantly stronger than its effect on APD (relative enhancement of SV). Similar effect could be observed with the selective I Ks blocker HMR 1556 (0.5 μM), which agent caused only a small, but statistically significant lengthening of APD combined with a pronounced increase in SV. This can be best visualized in Fig. 5h , where the ΔSV/ΔAPD values were displayed versus ΔAPD. The diamond representing HMR 1556 is located far above the curve in the positive ΔAPD range. This indicates that the SV-increasing effect of HMR 1556 is much greater than predicted by the earlier discussed APD-SV relationship-in spite of the fact that I Ks is considered to be a weak current in canine ventricular myocytes under baseline conditions [24, 26] . A relatively selective I to blockade can be achieved by applying chromanol 293B in the presence of HMR 1556 [25] . Exposure of myocytes to 100 μM chromanol 293B revealed that suppression of I to decreased SV without significant alterations in APD, a result similar to previously obtained with 1 mM 4-aminopyridine. That is why the downward triangle, indicating chromanol 293B, is located also far above the curve (Fig. 5h) . Increasing concentrations of lemakalim (0.1, 0.3, 1, and 5 μM) were used to shorten APD. Lemakalim decreased both SV and APD, but data points remained on the curve indicating that this current has little specific influence on SV. Suppression of I K1 with BaCl 2 (gradually increasing BaCl 2 concentration from 0.3 to 5 μM) increased APD and SV, but in this case the SV-increasing effect was weaker than predicted by the APD-SV relationship, suggesting that relative SV might be increased by I K1 . However, as it is clearly seen in Fig. 5d , BaCl 2 caused strong triangulation of action potentials, defined as a difference between the APD 90 and APD 50 values. Triangulation was 47±3 ms under control conditions, which increased to 90±11 ms in the presence of 5 μM BaCl 2 (p<0.05). Assuming that APD measured close to the plateau level may be more relevant to control action potential repolarization than APD 90 itself, data points obtained with 5 μM BaCl 2 should be shifted leftwards on the horizontal axis in Fig. 5f -h by 43 ms for the sake of better comparability. Considering these corrections due to triangulation, each BaCl 2 data point touched the exponential curve (not shown) indicating that I K1 is a current largely indifferent regarding the modulation of SV.
Contribution of inward currents
The role of Na + current (I Na ) was examined by suppression of I Na using TTX and lidocaine, or alternatively, by activation of the current by veratridine (Fig. 6a-c) . As expected, veratridine (10, 30, and 100 nM) increased both APD and SV in a concentration-dependent manner, while both parameters were simultaneously decreased by tetrodotoxin (TTX, 3 μM) and lidocaine (50 μM). Importantly, the SVdecreasing effect of I Na inhibition, as well as the enhancement of SV caused by veratridine, were larger than predicted by the APD-SV relationship (Fig. 6f-h) , congruently with an SV increasing action of I Na . The other inward current under investigation was the L-type Ca 2+ current (I Ca ). It was blocked by 1 μM nisoldipine and enhanced by 20 or 200 nM of BAY K8644 (Fig. 6d, e) . Nisoldipine increased SV (by 0.52±0.19 ms) while APD was strongly shortened (by 103±7 ms); both effects were statistically significant (p <0.05, n =19/13). BAY K8644 increased APD significantly in 20 nM as well as 200 nM concentrations (APD-lengthening of 38±4 and 82±8 ms was observed in 12/6 and 21/9 myocytes, respectively, p<0.05). SV was not altered by 20 nM BAY K8644, but it was increased by 1.96±0.26 ms in the presence of 200 nM BAY K8644. As demonstrated in Fig. 6f -h, these changes in SV corresponded to a relative reduction of SV when compared to the concomitant lengthening of APD. In other words, SV was strongly diminished by I Ca . Fig. 2c-e Offsetting the effects of APD changes
The best approach to separate the contribution of a specific ion current to modulating SV from the effect of the concomitant APD change is to apply an electrical or pharmacological compensation. The former strategy was used in the experiments presented in Fig. 7a-f , where the APDlengthening effects of 0.1 μM dofetilide, 5 μM BaCl 2 , 0.1 μM veratridine, and 0.2 μM BAY K8644 were offset using outward current pulses with constant, properly chosen amplitude. Similarly, the APD-shortening effects of 3 μM tetrodotoxin and 1 μM nisoldipine were compensated using inward current pulses (Fig. 7e, f) . After full compensation for the dofetilide-induced lengthening of APD, a significant elevation of SV persisted (Fig. 7a) , while in the case of BaCl 2 the enhancement of SV was eliminated by restoring the original value of APD. More specifically, SV, measured after compensation for the barium-induced lengthening of APD, fell below the control level of SV (Fig. 7b) . However, applying the argumentation used in the case of Fig. 5d , based on the barium-induced triangulation of action potentials, APD 50 was overcompensated by the applied outward current. This is in line with our previously discussed finding, i.e., suggesting that I K1 is really an indifferent current regarding its possible influence on SV. (Fig. 7c) -in contrast to BAY K8644, which resulted in a subnormal level of SVafter compensation for the APD changes (Fig. 7d) . When I Na was blocked by tetrodotoxin, the SV values were lower than control following compensation of APD (Fig. 7e) , while in the presence of the I Ca blocker nisoldipine, the drug-induced elevation of SV was further increased by the inward current pulse applied for offsetting the APD changes (Fig. 7f) .
Since one may argue that electrical compensation of APD changes may shift the membrane potential to one or another direction, pharmacological compensation was also used in some experiments (Fig. 7g-j) . In this case, the APDlengthening effects of dofetilide and veratridine were compensated by lemakalim (using properly chosen concentrations in each experiment), while the APD-shortening effects of tetrodotoxin and nisoldipine were compensated by BaCl 2 . Although these compensations resulted in full restoration of was compensated by outward currents (OC). Replacement of the suppressed I Na (3 μM tetrodotoxin, n=8/4, e) and I Ca (1 μM nisoldipine, n=10/5, f) was made by inward current pulses (IC). In these experiments drug effects on APD were fully offset with current injections having finely adjusted amplitudes so as the pre-drug and post-drug APD values were largely equal. The effects of dofetilide (0.3 μM, n= 5/4, g) and veratridine (0.1 μM, n=8/4, h) on APD were compensated by application of lemakalim, the activator of ATP-sensitive K + channels, while in the case of tetrodotoxin (3 μM, n=6/4, i) and nisoldipine (1 μM, n=7/4, j), properly chosen concentrations of BaCl 2 were applied to offset the APD changes. Columns and bars are means ± SEM; asterisks denote significant differences from control values the initial APD 90 values, SV remained elevated in the presence of dofetilide and veratridine, became higher than control in nisoldipine and lower than control in tetrodotoxin. In summary, electrical and pharmacological compensation strategies yielded largely identical results corroborating the specific SV-lowering effects of I Kr and I Ca , as well as the SVincreasing effects of I Na . It must be emphasized, however, that the most dramatic effect was observed with nisoldipine, independently of the way of compensation, highlighting the pivotal role of I Ca in controlling SV.
Effect of isoproterenol
Summarizing the results above, it could be concluded that two currents, namely I Ca and I Ks , were very effective in reducing the relative SV. If this is true, isoproterenol (ISO) is expected to decrease SV markedly, since this drug is known to increase both I Ca and I Ks simultaneously. ISO (10 nM) caused a small, although statistically significant shortening in APD at 1 Hz (reduction of 25±3 ms, p<0.05, n=13/5), which was accompanied with a robust decrease in SV (reduction of 0.89±0.09 ms, p<0.05, n=13/5), which was much larger than predicted by the APD-SV relationship (Fig. 8a-c) . Indeed, the lowest SV could be observed at close to normal APD values in the presence of 10 nM ISO. Since ISO is known to increase [Ca 2+ ] i , and changes in [Ca 2+ ] i were shown to influence relative SV, the effects of ISO were studied also after the exposure to 5 μM BAPTA-AM for 25 min. As seen previously, pretreatment with BAPTA-AM lengthened APD markedly without significantly affecting SV. In the presence of BAPTA-AM, SV was decreased and APD was shortened by ISO similarly to results observed without BAPTA-AM (Fig. 8d, e) . The effect of ISO on relative SV was largely similar in the presence and absence of BAPTA-AM, indicating that the effect of ISO on SV was not related to the concomitant changes in [Ca 2+ ] i , it was rather caused by the ISO-induced augmentation of I Ca and I Ks . Supporting this conclusion, ΔSV/ΔAPD values were identical in the absence and presence of BAPTA-AM (0.043±0.007 (n=13/5) and 0.045±0.009 (n=7/4), respectively, N.S.).
The effect of 10 nM ISO was studied also at various pacing cycle lengths. In these experiments, SV was determined by analyzing 10 consecutive action potentials only in order to limit the duration of the measurement. Although both the ISOinduced shortening of APD and reduction of SV increased with increasing the cycle length of stimulation (Fig. 8f, g ), the relative SV-as demonstrated in Fig. 8h -progressively decreased at longer cycle lengths.
Discussion
The main goal of the present study was to separate SV changes related to inhibition of a specific ion current from those attributable to concomitant changes in APD. This approach allows for separation of ion currents to APDstabilizing, therefore potentially antiarrhythmic currents (ones decrease relative SV) and to those which increase relative SV. Members of this latter group cause instability of APD; therefore, they can be considered potentially arrhythmogenic. Using these categories based on predictions of arrhythmia incidence, three currents could be identified as APD stabilizer: I Ca , I Ks , and I Kr . I Na and I to were found to increase instability of APD, while I K1 and I K-ATP appeared to be indifferent. These results provide an essentially new interpretation of beat-tobeat variability suggesting that the well-known negative feedback regulation of APD may be an important factor of SV modulation.
Effects of several ion channel modifiers (including dofetilide [12] , HMR 1556 [12] , ATX-II [12] , and isoproterenol [13] in canine, while tetrodotoxin [27] and intracellular EGTA [27] in guinea pig ventricular cells) on the magnitude of beat-to-beat variability have been extensively studied; however, the changes in SV were not correlated by the investigators with the concomitant APD changes. The first approach to make such a distinction was the recent study of Heijman et al. [6] , although it was an in silico analysis. Present results, however, have confirmed many of their predictions: I Na and I Kr have great impact on SV, I Kr is an APD-stabilizing, while I Na and I to are APD-unstabilizing currents. I Ks was estimated also as an APD-stabilizing current (having larger impact on SV than on APD)-in line with our observations, but only our analysis, based on comparison of ΔSV/ΔAPD changes, was able to highlight the importance of this interaction in the case of I Ks . The largest difference between our and their results was found in the role of I Ca . Although I Ca was considered to be APD-stabilizing by both studies, it was the most important modulator in our experiments, as indicated by the results obtained with nisoldipine and BAY K8644-in contrast to the moderate effect on SV proposed by the simulation in Fig. 3 of the study of Heijman et al. [6] .
According to the conventional interpretation of beat-tobeat variability, it is due to the stochastic behavior of ion channel gating [14, 18] . Without questioning the contribution of this mechanism, here we propose another (probably more relevant) one to explain the observed changes in SV. Physiological control of APD is based on the following well-known negative feedback regulation scheme: prolongation of APD (e.g., due to the enhancement of an inward current) results in elevation of the plateau, which in turn accelerates the activation of I Kr and I Ks leading finally to a shortening of APD. Accordingly, those currents which are known to be critical members of this feedback loop-namely I Ca , I Kr , and I Ks -are expected to decrease the variability of APD, and their inhibition may have an opposite effect. This interpretation provides some explanation for the following question: why I Ca decreases while late I Na increases APD. This is not evident since both currents are inwardly directed, tending to increase APD together with its variability. The crucial difference between I Ca and late I Na is that the former is active mainly during the initial part of the plateau [2] , while the latter is dominant during the late plateau [10, 28] . As a consequence, I Ca has a chance to shift the early plateau upwards allowing for faster and stronger activation of I Kr and I Ks , while in the case of late I Na these changes develop later in time and in a less pronounced way. In line with this, the SV-increasing effect of late I Na is strong because its activation overlaps the late plateau, where the membrane resistance is the highest [27] ; consequently, a relatively small inward shift in the net membrane current may result in a large prolongation of APD [3, 4] . This gives also the physical basis of the exponential relationship between SV and APD, as was predicted by the simulations of Heijman et al. [6] and confirmed experimentally by the present work.
In addition to action potential duration, the morphology of action potential was also suggested to be an important determinant of SV [6] . Heijman et al. simulated square-like action potential configuration by decreasing both I Ca and I to , while triangulation was achieved by strongly reducing I K1 . SV was dramatically elevated when it was simulated for a square-like action potential; on the contrary, triangulation decreased relative SV. Indeed, characteristic changes in action potential morphology can be attributed to modifications of many cardiac ion currents, e.g., suppression of I Ca by nisoldipine results in plateau depression and square-like morphology. Similarly, suppression of I K1 caused triangulation of action potentials, i.e., smaller increase of APD 50 than that of APD 90 . Since the plateau level is critical in the negative feedback regulation of APD, its duration is overestimated by APD 90 in case of triangulation. This is why I K1 can not be considered as a potentially proarrhythmic current in dogs in spite of the reduction of relative SV observed in BaCl 2 . Although modification of SV observed in these examples is likely mediated by a change in action potential morphology, this is not always the case. For example, exposure of EPI myocytes to 4-aminopyridine converted action potential morphology from EPI to ENDO, but SV was not increased accordingly. Furthermore, SV was reduced by ISO very effectively without causing triangulation.
Our results regarding the effects of the stimulation cycle length on SV is similar to those of Johnson et al. [12] , both studies showing an elevation of SV with increasing the cycle length. It might be tempting to associate these frequencydependent changes in SV with the corresponding changes in the amplitude of specific ion currents. Since I Ca is known to increase, while I Ks is to decrease with increasing the cycle length of stimulation, the value of this approach seems to be limited. However, we have shown also that at cycle lengths of 700 ms or longer, the changes in SV was likely due to the concomitant alterations of APD, since no change in relative SV could be observed within this frequency range. Specific cycle lengthdependent changes in SV could be observed only at the shortest cycle lengths, where [Ca 2+ ] i could probably be elevated. Indeed, manipulation of [Ca 2+ ] i resulted in the expected change in relative SV, which increased and decreased together with the changes in [Ca 2+ ] i . In line with this assumption, the ISOinduced reduction of relative SV also increased with increasing the cycle length of stimulation. Accordingly, the ISO-induced reduction of SV was not significant at the shortest cycle length of 0.3 s, while it became progressively dominant at longer cycle lengths (including the range between 0.5 and 1 s, corresponding to the physiological heart rate in humans). It can be speculated that the ISO-induced reduction of relative SV could partially be offset by the elevated [Ca 2+ ] i at faster driving rates. It is worth mentioning that alternans was not observed even at the shortest cycle length of 300 ms-in contrast to the results of Johnson et al. [12] . This was likely the consequence of the bicarbonate content of our Krebs solution, which is known to provide an excellent intracellular buffering, decreasing thus the probability of alternans [5] . We have intentionally chosen the simplest way to manipulate [Ca 2+ ] i , since both chelation of [Ca 2+ ] i and increasing the calcium entry using a calcium ionophore are expected to yield steady changes in [Ca 2+ ] i , relatively independent of the cardiac cycle. This allowed a qualitative prediction of SV changes associated with variation of [Ca 2+ ] i , but is obviously not suitable for modeling the consequences of dynamic [Ca 2+ ] i changes occurring when transports between the sarcoplasmic reticulum and the cytosol are active. In this investigation, the possible contribution of one or another ion current to SV was studied by using specific activators and inhibitors of the ion channel in question. We tried to apply these agents in relatively selective concentrations (i.e., at concentrations resulting dominantly action on the targeted ion channel), while in some cases a series of concentrations have been applied. Serious problem with drug selectivity arose only in the case of 4-aminopyridine, which is not selective blocker of I to -not even at the concentration of 1 mM. Therefore, selective suppression of I to could be only achieved by using 100 μM chromanol 293B (of course in the presence of HMR 1556, since chromanol 293B is also known to inhibit I Ks ). Regarding the Ca 2+ ionophore A 23187 and the Ca 2+ chelator BAPTA-AM, the applied concentrations (1 and 5 μM, respectively) were chosen by convention, since the amount of calcium entry or calcium chelation depends primarily on the time of exposure.
In addition to the better understanding of the mechanism of beat-to-beat variability, there is one-quite annoying-practical implication of the present work. We have shown that I Kr , I Ks , and I Ca act to reduce short-term variability. These are the currents being generally suppressed by classes 3 and 4 antiarrhythmics, respectively. Furthermore, 10 nM ISO was the most effective agent to diminish relative SV out of all drugs tested. Class 2 antiarrhythmics, which are beta-receptor blockers, are expected to suppress this apparently beneficial adrenergic activity. Although we do not intend to suggest that adrenergic activation itself would be antiarrhythmic, it must be clearly seen that it has antiarrhythmic properties as well. Putting together, almost all of the presently applied antiarrhythmic agents (including the less side effect carrying beta-blockers) may potentially increase the beat-to-beat variability of action potential duration limiting this way their antiarrhythmic potencies.
